Lewis Arthurton

Lewis Arthurton

Auto-generated profile, based on publicly available information

Lewis Arthurton

Alzheimer’s Disease International, London, UK

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2018 in Seminars in Cell & Developmental Biology
Verified
Journal Article
Open access
LLLuis Alberto Baena Lopez
Luis Alberto Baena Lopez
LALewis Arthurton
Lewis Arthurton
DXDerek Cui Xu
Derek Cui Xu
AGAlessia Galasso
Alessia Galasso
The evolutionarily conserved family of proteins called caspases are the main factors mediating the orchestrated programme of cell suicide known as apoptosis. Since this protein family was associated with this essential biological function, the majority of scientific efforts were focused towards understanding their molecular activation and function during cell death. However, an emerging body of evidence has highlighted a repertoire of non-lethal roles within a large variety of cell types, including stem cells. Here we intend to provide a comprehensive overview of the key role of caspases as regulators of stem cell properties. Finally, we briefly discuss the possible pathological consequences of caspase malfunction in stem cells, and the therapeutic potential of caspase regulation applied to this context.

14 May 2015 in The Journal of Physiology
Verified
Journal Article
Open access
PDF file
SBSimona Boncompagni
Simona Boncompagni
LALewis Arthurton
Lewis Arthurton
EAEugene Akujuru
Eugene Akujuru
TPTimothy Pearson
Timothy Pearson
DSDietmar Steverding
Dietmar Steverding
GMGabriel Mutungi
Gabriel Mutungi
Key points: Many studies have previously suggested the existence of stress hormone receptors on the cell membrane of many cell types, including skeletal muscle fibres; however, the exact localisation of these receptors and how they signal to the rest of the cell is poorly understood. In this study, we investigated the localisation and the mechanism(s) underlying the physiological functions of these receptors in mouse skeletal muscle cells. We found that the receptors were present throughout muscle development and that, in adult muscle fibres, they were localised in the extracellular matrix, satellite cells (muscle stem cells) and close to mitochondria. We also found that they signalled to the rest of the cell by activating enzymes called mitogen‐activated protein kinases. From these results we suggest that, at physiological concentrations, stress hormones may be important in skeletal muscle differentiation, repair and regeneration. A number of studies have previously proposed the existence of glucocorticoid receptors on the plasma membrane of many cell types, including skeletal muscle fibres. However, their exact localisation and the cellular signalling pathway(s) they utilise to communicate with the rest of the cell are still poorly understood. In this study, we investigated the localisation and the mechanism(s) underlying the non‐genomic physiological functions of these receptors in mouse skeletal muscle cells. The results show that the receptors were localised in the cytoplasm in myoblasts, in the nucleus in myotubes, in the extracellular matrix, in satellite cells and in the proximity of mitochondria in adult muscle fibres. Also, they bound laminin in a glucocorticoid‐dependent manner. Treating small skeletal muscle fibre bundles with the synthetic glucocorticoid beclomethasone dipropionate increased the phosphorylation (= activation) of extracellular signal‐regulated kinases 1 and 2, c‐Jun N‐terminal kinase and p38 mitogen‐activated protein kinase. This occurred within 5 min and depended on the fibre type and the duration of the treatment. It was also abolished by the glucocorticoid receptor inhibitor, mifepristone, and a monoclonal antibody against the receptor. From these results we conclude that the non‐genomic/non‐canonical physiological functions of glucocorticoids, in adult skeletal muscle fibres, are mediated by a glucocorticoid receptor localised in the extracellular matrix, in satellite cells and close to mitochondria, and involve activation of the mitogen‐activated protein kinase pathway.

13 January 2025 in Nature Reviews Neurology
Verified
Journal Article
Closed access
PDF file
LALewis Arthurton
Lewis Arthurton
PBPaola Barbarino
Paola Barbarino
RARobert Anderson
Robert Anderson
BSBen Schlaepfer
Ben Schlaepfer
NSNazak Salehi
Nazak Salehi
MKMartin Knapp
Martin Knapp

29 April 2018 in BioMed Research International
Verified
Journal Article
Open access
PDF file
DXDerek Cui Xu
Derek Cui Xu
LALewis Arthurton
Lewis Arthurton
LLLuis Alberto Baena Lopez
Luis Alberto Baena Lopez
The ease of genetic manipulation, as well as the evolutionary conservation of gene function, has placedDrosophila melanogasteras one of the leading model organisms used to understand the implication of many proteins with disease development, including caspases and their relation to cancer. The family of proteases referred to as caspases have been studied over the years as the major regulators of apoptosis: the most common cellular mechanism involved in eliminating unwanted or defective cells, such as cancerous cells. Indeed, the evasion of the apoptotic programme resulting from caspase downregulation is considered one of the hallmarks of cancer. Recent investigations have also shown an instrumental role for caspases in non-lethal biological processes, such as cell proliferation, cell differentiation, intercellular communication, and cell migration. Importantly, malfunction of these essential biological tasks can deeply impact the initiation and progression of cancer. Here, we provide an extensive review of the literature surrounding caspase biology and its interplay with many aspects of cancer, emphasising some of the key findings obtained fromDrosophilastudies. We also briefly describe the therapeutic potential of caspase modulation in relation to cancer, highlighting shortcomings and hopeful promises.

17 September 2018 in bioRxiv
Verified
Preprint
Open access
PDF file
LLLuis Alberto Baena Lopez
Luis Alberto Baena Lopez
LALewis Arthurton
Lewis Arthurton
MBMarcus Bischoff
Marcus Bischoff
JVJean-Paul Vincent
Jean-Paul Vincent
CACyrille Alexandre
Cyrille Alexandre
RMReuben McGregor
Reuben McGregor
The caspase-mediated regulation of many cellular processes, including apoptosis, justifies the substantial interest in understanding all of the biological features of these enzymes. To complement functional assays, it is critical to identify caspase-activating cells in live tissues. Our work describes new caspase-reporters that, for the first time, provide direct information concerning the initial steps of the caspase activation cascade in Drosophila tissues. One of our caspase-sensors has capitalized on the rapid subcellular localization change of a fluorescent marker to uncover novel cellular apoptotic events. These refer to the actin-mediated positioning of the nucleus before cell delamination. The other construct has benefited from a caspase-induced nuclear translocation of a QF transcription factor. This feature enables the genetic manipulation of caspase-activating cells, whilst showing the spatio-temporal patterns of apical caspase activation. Collectively, our sensors offer new experimental opportunities that are already illuminating unknown aspects of caspase-dependent processes in apoptotic and non-apoptotic cellular scenarios. Summary statement: We describe a novel set of caspase sensors that directly detect early caspase activation. The exclusive features of our reporters uncovered unknown stages of apoptosis and properties of caspase-activating cells.

25 December 2023 in Alzheimer's & Dementia
Verified
Journal Article
Open access
LALewis Arthurton
Lewis Arthurton
CLChris Lynch
Chris Lynch
Background: In 2017, all 194 Member States of the World Health Organization (WHO) unanimously adopted the Global Action Plan on the public health response to dementia 2017‐2025, the primary aim being for countries to implement National Dementia Plans (NDP). However, as outlined in Alzheimer’s Disease International’s (ADI) recent From Plan to Impact report, WHO Member States have been far too slow to act ‐ falling far short of the 146 countries target. In response, ADI launched the #WhatsYourPlan campaign, in collaboration with ADI Members, with the single‐minded aim of galvanising governments to act on their 2017 commitment.Method: Strategizing and working with ADI Members, official communications were sent to relevant ministries to enquire as to the status of the NDP, and to request a formal meeting. For Ministries where a response was not obtained, subsequent letters were sent to elicit a response. ADI has also, in some instances, sought advice and utilised WHO regional and national offices, and other multilateral bodies and stakeholders, to help follow up with Ministries of Health for those that have been willing to engage.Result: To date, 52 ADI members and thus 52 countries have joined the campaign. In total from the onset of the campaign, over 205 official communications have been shared with Member States, resulting in a total of 29 high‐level meetings. In total 20 Member States have committed to developing an NDP, just over a third of all participating ADI Members and over half of the number of plans already in existence in WHO Member States.Conclusion: Only with robust NDPs can governments prepare their health and care systems to meet the complex needs of those affected by dementia. As ADI moves forwards into the second year of the campaign, the mission and scope remain, however with added urgency as the 2025 deadline gets nearer. The campaign will expand accordingly through awareness raising campaigns, media and social media engagement, and regional ADI/WHO meetings, whilst solidifying the successes of the previous year. Ultimately, with the intention of educating the public on why NDPs are so important, and to empower them to ask their own governments: #WhatsYourPlan?